Developing tests to detect and identify infectious agents in humans
Official title: Task Area E: NIAID Preclinical Services for AMR Diagnostics Development
Funded at Midwest Research Institute · NIH-10913855 · Data updated 2026-11-12
This study is working on better tests to quickly and accurately identify tough bacteria that don't respond to antibiotics, so doctors can treat infections more effectively and help patients get better faster.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Midwest Research Institute NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project start | June 20, 2023 |
| Project end | June 19, 2030 |
| Funding year | 2023 |
| Award (this year) | $3,500 |
| NIH project number | 75N93023D00017-0-759302300002-1 |
| Project ID | NIH-10913855 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who are suspected of having infections caused by antibiotic-resistant bacteria.
✕Less likely to help
Patients with infections caused by non-resistant bacteria may not receive direct benefits from this research.
What this research studies
This research focuses on creating and improving diagnostic tests that can detect and identify infectious agents, particularly bacteria that are resistant to antibiotics. The approach involves developing various assays and platforms that can accurately characterize these pathogens, which is crucial for effective treatment. By enhancing the capabilities for in vitro diagnostic (IVD) product development, the research aims to provide healthcare professionals with better tools to manage infections. Patients may benefit from more accurate and timely diagnoses, leading to improved treatment outcomes.
Why it matters
Potential benefit: If successful, this research could lead to more effective diagnostic tools for detecting antibiotic-resistant infections, improving patient care.
How similar studies have gone: Other research has shown success in developing diagnostic tests for infectious agents, indicating that this approach has potential for meaningful advancements.
Where this research is happening
-
Midwest Research Institute
Kansas City, United States Active
Researchers
- Principal investigator: Girard, Yvette — Midwest Research Institute
- Study coordinator: Girard, Yvette
Related research
Other NIH-funded projects on the same topics.
-
BRIDGE Center: A shared biomanufacturing hub to move biologics and cell therapies toward clinic
A new shared facility will help speed up the development and early clinical testing of vaccines, biologics, and cell-based therapies.
-
Developing a new treatment for tuberculosis called Telacebec.
This study is testing a new medication called Telacebec (Q203) to see if it can help people with tuberculosis by making treatment safer and more effective, which could lead to shorter recovery times and better health outcomes.
-
Creating a new type of DNA vaccine for better immune responses
This study is testing a new type of vaccine made from DNA that could help boost your immune system against different diseases, and it's designed to be safe and effective for people like you.
-
Developing a live biotherapeutic to improve vaginal health
This study is testing a new treatment made from good bacteria to help women with bacterial vaginosis and improve their vaginal health, which may also lower the risk of cervical issues.
-
Understanding and improving pain management.
This study is all about finding quicker and better ways to understand and manage pain, so that people dealing with different pain conditions can get more effective treatments and feel better.
-
A centralized resource for cancer prevention agents and support services
This study is creating a central place to store and manage cancer-fighting substances to help researchers find better ways to prevent cancer, making it easier for them to conduct their important work.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.